Endotronix
Deal: $12 million in debt financing
Investors: Silicon Valley Bank
What they do: Woodridge, Ill.-based Endotronix is a health tech company that helps patients monitor their heart condition. The company has built an implantable wireless pulmonary artery sensor and a cloud-based disease management data system, and it allows patients with advanced heart failure to measure their heart pressure each day via a handheld device. Doctors can access the data through the cloud, and help diagnose problems before it's too late. The company said the debt financing will be used to support the clinical program of its Cordella Heart Failure System.
Other details: The round of funding comes after the company raised a $32 million Series C last July, which included investment from BioVentures Investors, SV Life Sciences, Lumira Capital, Aperture Venture Partners, OSF Ventures and other investors. Founded in 2007, Endotronix has raised over $60 million in equity and debt.
"This financing builds on our recent Series C round and we are thrilled to be working with the SVB team," Endotronix CEO Harry Rowland said in a statement. "We look forward to advancing our clinical program with proactive heart failure management that simplifies at-home care and improves patient outcomes."
Screengrab via Endotronix
